multiple sclerosis

Biogen

Marketing

Biogen investigated by Italian regulator on ‘market abuse’ claims

Italy’s antitrust agency is investigating Biogen over claims it is abusing its market position regarding a test for MS drug Tysabri.

Ben Adams May 27, 2026 7:38am

Merck of Germany

Merck KGaA expects Mavenclad generics to deal serious blow in US

Mar 5, 2026 11:30am

Graham

Roche eyes busy 2026 despite Vabysmo miss, Tecentriq flop

Jan 29, 2026 11:23am

An envelope with rejected mark Vector illustration

Fierce Biotech

FDA shares CRL for Sanofi MS drug mere weeks after rebuff

Jan 6, 2026 4:30am

Genentech Hidden GeMS campaign

Genentech uncovers 'Hidden GeMS' in latest #MSVisibility drive

Dec 9, 2025 4:05pm

Sandoz

Sandoz's biosimilar to Biogen's Tysabri hits the US after delay

Nov 17, 2025 11:12am